Literature DB >> 6881181

Neoplastic meningitis. Marked variations of cerebrospinal fluid composition in the absence of extradural block.

J J Murray, F A Greco, S N Wolff, J D Hainsworth.   

Abstract

Cerebrospinal fluid levels of protein, glucose, and malignant cells may differ markedly at different levels of the neuraxis in patients with neoplastic meningitis, even in the absence of an extradural blockage to cerebrospinal fluid flow. The pathogenesis of these differences is unclear, but is probably related to focal disruption of the blood-cerebrospinal fluid barrier produced by neoplastic involvement of the meninges. The clinical implications of this new observation are important. When the diagnosis of neoplastic meningitis is strongly suspected, but malignant cells cannot be demonstrated by repeated examination of lumbar cerebrospinal fluid, samples should be obtained by cisternal tap if the neurologic deficits are manifestations from involvement of the cranial nerves or cerebrum. Similarly, response to intrathecal chemotherapy should be monitored with serial examinations of cerebrospinal fluid obtained from the site of most marked pretreatment abnormality.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6881181     DOI: 10.1016/0002-9343(83)91207-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

Review 1.  Meningeal metastases: clinical aspects and diagnosis.

Authors:  F Formaglio; A Caraceni
Journal:  Ital J Neurol Sci       Date:  1998-06

Review 2.  Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee.

Authors:  Katherine E Warren; Gilbert Vezina; Tina Y Poussaint; Monika Warmuth-Metz; Marc C Chamberlain; Roger J Packer; Alba A Brandes; Moshe Reiss; Stewart Goldman; Michael J Fisher; Ian F Pollack; Michael D Prados; Patrick Y Wen; Susan M Chang; Christelle Dufour; David Zurakowski; Rolf D Kortmann; Mark W Kieran
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

Review 3.  Leptomeningeal metastases from solid malignancy: a review.

Authors:  Sophie Taillibert; Florence Laigle-Donadey; Catherine Chodkiewicz; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

Review 4.  Leukemic and lymphomatous meningitis: incidence, prognosis and treatment.

Authors:  Marc C Chamberlain; Craig Nolan; Lauren E Abrey
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

5.  Papilloedema and lymphocytic meningitis in a 68 year old man.

Authors:  C Allen; J Bell; H McNaughton; C Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

6.  Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.

Authors:  A P van Zanten; A Twijnstra; B W Ongerboer de Visser; P van Heerde; A A Hart; W J Nooyen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

7.  A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.

Authors:  Morris D Groves; Vinay K Puduvalli; Susan M Chang; Charles A Conrad; Mark R Gilbert; Ivo W Tremont-Lukats; Ta-Jen Liu; Pamela Peterson; David Schiff; Timothy F Cloughesy; Patrick Y Wen; Harry Greenberg; Lauren E Abrey; Lisa M DeAngelis; Kenneth R Hess; Kathleen R Lamborn; Michael D Prados; W K Alfred Yung
Journal:  J Neurooncol       Date:  2006-09-22       Impact factor: 4.130

8.  Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.

Authors:  A Twijnstra; B W Ongerboer de Visser; A P van Zanten; A A Hart; W J Nooyen
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

9.  Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors.

Authors:  Fusako Waki; Masashi Ando; Atsuo Takashima; Kan Yonemori; Hiroshi Nokihara; Mototaka Miyake; Ukihide Tateishi; Koji Tsuta; Yasuhiro Shimada; Yasuhiro Fujiwara; Tomohide Tamura
Journal:  J Neurooncol       Date:  2008-11-29       Impact factor: 4.130

10.  Meningeal carcinomatosis from breast cancer: spinal cord vs. brain involvement.

Authors:  G Clamon; B Doebbeling
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.